• CLINICAL INTEREST SECTIONS: Coronary Peripheral TAVR Center

  • SCAI This Week
  • August 10, 2012

    In This Issue:

     


     

     


     

    Don't Wait! Enrollment for SCAI 2012 Fall Fellows Courses is Quickly Filling

    Attention interventional cardiology fellows-in-training, training program directors and coordinators. Enrollment is filling quickly for SCAI 2012 Fall Fellows Courses in Adult Interventional Cardiology and Congenital & Structural Disease.

    Featuring a streamlined schedule, an all-new location at The Cosmopolitan of Las Vegas, and a faculty of the biggest names in interventional cardiology, SCAI Fall Fellows is the must-attend meeting for fellows-in-training.

    If you are serving in the fourth year of your interventional cardiology fellowship, or serving in the third or fourth year of your pediatric cardiology fellowship and interested in cardiac catheterization, you qualify to register for SCAI's Fall Fellows Course, which includes:

    • FREE Tuition, Travel & Hotel (restrictions apply)
    • WORLD CLASS FACULTY featuring the Best of the Best in Interventional Cardiology
    • HANDS-ON simulation training
    • UPDATES on the most widely used interventional procedures

    Don't Wait! Applications for the Fall Fellows Scholarship are Due September 14

    Download the Preliminary Program

    Find Out About FREE SCAI Membership for Interventional FITs

    Back to Top



    Catch Up With All the Science Presented at SCAI 2012, Starting at Just $249

    Drawing record attendance and rave reviews, SCAI 2012 Scientific Sessions was IMPORTANT, INTENSE, INSPIRING, and a whole lot of FUN in Las Vegas. In other words, it was a can't-miss program.

    However, if you did miss it, you can still catch up with all the science, the debates, case reviews and clinical revelations with SCAI 2012 On Demand.

    Starting at just $249 for non-attendee members, SCAI 2012 On Demand captures all the educational content from SCAI 2012 Scientific Sessions, bringing you multimedia re-creations with audio synchronized with slides which can be viewed from your PC or laptop or on your iPhone or iPad while you are on the go. Content will be available through May 1, 2013.

    Purchase SCAI 2012 On Demand Now!

    Save the Date for SCAI 2013 in Orlando

    Back to Top


    Miss SCAI President Dr. Marshall's Message Earlier this Week? Here It Is

    August 7, 2012

    Dear Members,

    Last night, the New York Times released a story about a Department of Justice investigation of interventional procedures performed at HCA hospitals in Florida, and several news stories have followed. SCAI is aware of this issue, has spoken with reporters at the Wall Street Journal, and is reaching out to others who are working on this story as it unfolds.

    This event illustrates the importance of quality improvement for every SCAI member and the essential need to have an unrelenting commitment to this responsibility as physicians. To this end, SCAI tools, including our Quality Improvement Toolkit (QIT), appropriate use criteria, ACE accreditation program, clinical guidelines, and continued peer-reviewed clinical research, are in place with the goal of improving cardiovascular patient care. For more than 30 years, SCAI has focused on evidence-based medicine to continuously improve the care for interventional patients and this remains our primary focus today.

    I invite you to share your thoughts as this story evolves. Please send your comments to me at president@scai.org.


    J. Jeffrey Marshall, MD, FSCAI, FACC
    SCAI President

    Back to Top


    CCI Early View Study Examines Arteriotomy Closure Device Safety After PCI

    In order to get critical information to members as soon as possible, SCAI's official journal Catheterization & Cardiovascular Interventions (CCI), offers accepted manuscripts online in its Early View Section prior to inclusion of that manuscript in a print issue.

    The following Early View article is now available online - just log in at www.SCAI.org.

    Coronary Artery Disease

    Original Studies

     

    Arteriotomy closure device safety after percutaneous coronary intervention in the direct thrombin inhibitor era
    Gus Theodos, Chad Raymond, Matthew C. Becker, Julie Thornton, Stephen G. Ellis, Deepak L. Bhatt and Russell E. Raymond
    ABSTRACT | Members CLICK HERE to Access CCI

    Back to Top


    Class I Recall for Multi-Lumen Venous Catheterization Set

    FDA has issued a Class I recall notice relating to Teleflex subsidiary Arrow International's Multi-Lumen Venous Catheterization Set, following the company's May Field Corrective Action Letter.

    On May 3, Arrow international Inc. sent its distributors an Urgent Field Correction Action letter asking for the quarantining of any affected inventory of product manufactured from June 28, 2010 through March 4, 2012 and distributed from December 9, 2010 through February 29, 2012. Part and Lot numbers affected are available on the FDA's recall page.

    The recall comes because the device's labeling erroneously states that the product "contains no medication," while in reality the device contains chlorhexidine and silver sulfadiazine. Additionally, the product's label is missing the appropriate chlorhexidine contraindication.

    According to the recall notice, if a patient with a known or unknown allergy/sensitivity to chlorhexidine or silver sulfadiazine/sulfa drug is exposed to this product, there is the potential for an allergic reaction such as a delayed rash, hives or potentially an immediate Type 1, IgE mediated anaphylaxis (loss of blood pressure, bronchospasm and vascular collapse).

    This product may cause serious adverse health consequences, including death, if used in a patient who is allergic to either chlorhexidine or silver sulfadiazine, which is why the recall has been tagged Class I, the most serious type and reserved for situations in which there is a reasonable probability that use of the product will cause serious adverse health consequences or death.

    Read the Recall Notice

    Back to Top


    Register Now! Discounted Tuition for TRIP Chicago Expires at Midnight

    Today is the final day to take advantage of the advance registration discount for SCAI's Transradial Interventional Program (TRIP) Chicago is quickly approaching. Register by midnight and save!

    Led by Program Co-chairs Sunil V. Rao, MD, FSCAI and Samir B. Pancholy, MD, FSCAI, the faculty consists of some of the most highly trained and well respected transradial experts in Chicago, including Sandeep Nathan, MD, FSCAI, Adhir Shroff, MD, FSCAI, and Bernadette Speiser, BSN, MSN, CCRN.

    TRIP Chicago will offer a dynamic mix of didactic lectures, a nurse/tech symposium, case reviews and one-on-one structured simulation training.

    Advanced Content Includes:

    • Traversing difficult anatomy
    • Difficult interventional substrates
    • Transradial peripheral intervention
    • Nursing / tech symposium
    • Case based education
    • Structured simulator curriculum with one-on-one faculty interaction

    Nurse/Tech Content Includes:

    • Equipment needs
    • Room arrangements for radial vs. femoral
    • Radial artery policy
    • TR band policy and competency
    • Hemostasis removal documentation flow sheets
    • Same day PCI
    • Staff education requirements and plan for implementation
    • Financial investments / savings

    Discounted Registration Ends Today - RSVP NOW

    Information on Hotel Accommodations

    View the Agenda

    Find Out More About the Structured Simulator Curriculum

    Back to Top



    eLearning Spotlight: PVD Online Designed to Meet All Knowledge Levels

    Feedback from SCAI's membership has consistently ranked educational opportunities in peripheral vascular disease as a primary interest. That's why the Society is so excited to announce the release of the SCAI Peripheral Vascular Disease Online Curriculum, the newest addition to the Society's menu of online educational offerings.

    "The course is designed for all physicians, regardless of their background in PVD," said Course Director Christopher J. White, MD, FSCAI. "By providing information on basic as well as advanced aspects of PVD, we are able to offer a course that is just as useful to experts as it is to physicians just getting into this area"

    Offering up to 15 CME credit hours and ideal for physicians interested in learning the background, potential complications, and treatment options for peripheral vascular disease, Peripheral Vascular Disease Curriculum Online features 24/7 access to 15 modules that operate as an online textbook of information. Each module includes a slide presentation as well as a pre- and post-tests to help you assess your learning. Navigating through presentations is easy due to several key features, including expanded search capabilities that allow physicians to search for key terms and phrases within the text and audio to quickly target information.

    Find Out More About SCAI Peripheral Vascular Disease Curriculum Online

    Back to Top